IRIS
MISSO, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.013
NA - Nord America 2.741
AS - Asia 2.058
SA - Sud America 317
AF - Africa 29
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.164
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.719
RU - Federazione Russa 1.142
SG - Singapore 700
IE - Irlanda 554
CN - Cina 491
IT - Italia 419
BR - Brasile 280
HK - Hong Kong 264
DE - Germania 213
GB - Regno Unito 201
UA - Ucraina 185
VN - Vietnam 158
KR - Corea 148
JP - Giappone 96
FI - Finlandia 72
FR - Francia 57
GR - Grecia 56
IN - India 54
TR - Turchia 52
SE - Svezia 31
PK - Pakistan 25
AT - Austria 17
BE - Belgio 15
CO - Colombia 11
CZ - Repubblica Ceca 11
ID - Indonesia 11
IR - Iran 11
AR - Argentina 10
CA - Canada 10
ZA - Sudafrica 9
ES - Italia 8
NL - Olanda 8
PL - Polonia 8
IQ - Iraq 7
BD - Bangladesh 6
EC - Ecuador 6
MA - Marocco 6
MX - Messico 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
IL - Israele 4
TW - Taiwan 4
CL - Cile 3
KE - Kenya 3
PY - Paraguay 3
SA - Arabia Saudita 3
SC - Seychelles 3
TN - Tunisia 3
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
JM - Giamaica 2
LT - Lituania 2
MD - Moldavia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
DM - Dominica 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MG - Madagascar 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.164
Salva come PNG Salva come JPEG
Città #
Dallas 563
Dublin 554
Moscow 384
Singapore 326
Santa Clara 318
Chandler 308
Jacksonville 300
Hong Kong 263
Seoul 145
Ashburn 118
Beijing 90
Hefei 82
Ann Arbor 81
New York 77
Dong Ket 72
Princeton 69
Medford 61
Bremen 60
Naples 56
Roxbury 53
Boardman 51
Caserta 42
Bengaluru 40
Aversa 37
Ho Chi Minh City 36
Woodbridge 36
Munich 29
Wilmington 29
Des Moines 24
São Paulo 24
Los Angeles 23
The Dalles 23
San Mateo 20
Napoli 19
Nuremberg 19
Brussels 15
Helsinki 15
Milan 15
Mountain View 15
Falkenstein 14
Brno 11
Cambridge 11
Hanoi 10
San Nicola la Strada 10
Rio de Janeiro 9
Rome 9
Tianjin 9
Vienna 9
Zhengzhou 9
Bahawalpur 8
Brasília 8
Falls Church 8
Istanbul 8
San Francisco 8
Warsaw 8
Cava Dei Tirreni 7
Düsseldorf 7
London 7
Belo Horizonte 6
Council Bluffs 6
Frankfurt am Main 6
Guangzhou 6
Johannesburg 6
Lappeenranta 6
Nanjing 6
Piscataway 6
Viterbo 6
Auburn Hills 5
Avellino 5
Boston 5
Brooklyn 5
Curitiba 5
Houston 5
Jakarta 5
Shenzhen 5
Biên Hòa 4
Changsha 4
Chicago 4
Ercolano 4
Fortaleza 4
Goiânia 4
Guarulhos 4
Gunzenhausen 4
Haiphong 4
Hangzhou 4
Newark 4
Norwalk 4
Paris 4
Roubaix 4
Salvador 4
Secaucus 4
Shanghai 4
Taipei 4
Afragola 3
Amsterdam 3
Anápolis 3
Bascape 3
Betim 3
Campinas 3
Canoas 3
Totale 4.849
Salva come PNG Salva come JPEG
Nome #
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 170
Mitochondria as playmakers of apoptosis, autophagy and senescence 143
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 140
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 137
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 132
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 130
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 127
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 125
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 121
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 119
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 116
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion 116
Poorly differentiated neuroendocrine larynx carcinoma: Clinical features and mirnas signature—a new goal for early diagnosis and therapy? 115
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 113
Gene interference strategies as a new tool for the treatment of prostate cancer 112
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 111
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. 109
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 108
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 107
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 105
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 104
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 104
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports 104
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 103
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 103
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis 103
Emerging pathways as individualized therapeutic target of multiple myeloma. 102
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 102
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 101
Immune cell infiltration and inflammatory landscape in primary brain tumours 100
Bisphosphonates and cancer: what opportunities from nanotechnology? 100
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 100
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 99
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 98
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 98
Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. 97
microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics 95
Tumour-specific uptake of anti-cancer drugs: the future is here. 94
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 94
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 93
Optimal Management of Prostate Cancer Based on its Natural Clinical History 93
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. 92
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients. 92
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. 91
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems 91
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 91
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. 89
MOLECULAR TARGETS FOR THE TREATMENT OF MULTIPLE MYELOMA 88
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians 88
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 87
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 86
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 86
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 86
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. 85
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 85
Mir-34: a new weapon against cancer? 84
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 83
Measurement of autophagy by flow cytometry 83
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer 82
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 82
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 82
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 81
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis). 81
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 81
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 80
Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane 79
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 79
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 78
Lipid Nanoparticles to Deliver miRNA in Cancer 78
Nanoparticelle e loro usi 77
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. 77
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 77
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 75
Role of perineural invasion as a prognostic factor in laryngeal cancer 75
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response 75
Hepatocarcinoma: genetic and epigenetic features 74
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 72
Flexible 3D nanofiber-based SERS biosensor for detection of miRNA-223-3p in early Laryngeal Cancer diagnosis 71
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. 71
MICRO-RNAs as biological markers for prevention and diagnosis of oral carcinomas 71
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma 70
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research 68
Non-coding RNAs as a new dawn in tumor diagnosis 65
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review 64
Tissue expression of miR-449a as risk factor for occult neck metastasis in patients with cT3-T4 N0 laryngeal cancer. A pilot study 63
Prognostic patterns for predicting lymph node metastasis in patients with squamous cell carcinoma of the larynx 63
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection 60
Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors? 55
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(Iii) complex with superior anticancer bioactivity 55
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 55
Proteomic profiling identifies miR-423-5p as a modulator of oncogenic metabolism in HCC 26
Complex genetic landscape in CLL: Clinical impact on patients’ survival and insights into the altered molecular pathways 26
MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction 21
Totale 8.419
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.527
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021336 0 0 0 0 0 13 64 47 29 42 61 80
2021/2022444 23 12 1 7 147 11 6 14 18 25 43 137
2022/20231.138 125 19 18 118 104 121 4 63 506 19 23 18
2023/2024645 35 15 90 29 148 82 7 23 37 9 46 124
2024/20251.464 27 31 6 85 232 195 209 119 226 117 123 94
2025/20263.216 280 388 859 281 568 840 0 0 0 0 0 0
Totale 8.419